Crossref
Dexmedetomidine for sedation and correction of psychoemotional disorders in critically ill patients with COVID-19
Journal of Life Science and Biomedicine · 2021
DOI: 10.51145/jlsb.2021.10 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Life Science and Biomedicine, 2021. Verfasst von Ravshan Aliyevich Ibadov und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Ibadov, R. A., ARIFJANOV, A. S., IBRAGIMOV, R. K., & KHAKIMOV, B. B. (2021). Dexmedetomidine for sedation and correction of psychoemotional disorders in critically ill patients with COVID-19. Journal of Life Science and Biomedicine. https://doi.org/10.51145/jlsb.2021.10
Vancouver
Ibadov RA, ARIFJANOV AS, IBRAGIMOV RK, KHAKIMOV BB. Dexmedetomidine for sedation and correction of psychoemotional disorders in critically ill patients with COVID-19. Journal of Life Science and Biomedicine. 2021. doi:10.51145/jlsb.2021.10
BibTeX
@article{Ibadov2021,
author = {Ibadov, Ravshan Aliyevich and ARIFJANOV, Anvar Shamkhatovich and IBRAGIMOV, rdor Khamdamovich and KHAKIMOV, Begali Bobokulovich},
title = {Dexmedetomidine for sedation and correction of psychoemotional disorders in critically ill patients with COVID-19},
journal = {Journal of Life Science and Biomedicine},
year = {2021},
doi = {10.51145/jlsb.2021.10}
}
EUVIMED